Literature DB >> 7614491

Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease.

R B Bestetti1, J Coutinho-Netto, L Staibano, L Z Pinto, G Muccillo, J S Oliveira.   

Abstract

The aim of this study was to assess the peripheral and cardiac autonomic system by catecholamine measurements in patients with severe chagasic and nonchagasic heart failure. Fifteen chagasic and 16 nonchagasic patients were enrolled in the study. Plasma venous norepinephrine levels (pg/ml) were 397.26 +/- 250.11 for chagasic and 660.05 +/- 455.57 for nonchagasic patients (p > 0.05), plasma venous epinephrine levels 215.84 +/- 254.04 for chagasic and 106.17 +/- 65.90 for nonchagasic patients (p > 0.05), aortic root norepinephrine levels 435.46 +/- 306.60 for chagasic and 668.16 +/- 512.82 for nonchagasic patients (p > 0.05), aortic root epinephrine levels 300.33 +/- 302.69 for chagasic and 199.98 +/- 162.88 for nonchagasic patients (p > 0.05), coronary sinus norepinephrine levels 636.10 +/- 495.22 for chagasic and 552.17 +/- 535.54 for nonchagasic patients (p > 0.05) and coronary sinus epinephrine levels 226.66 +/- 277.47 for chagasic and 69.21 +/- 35.62 for nonchagasic patients (p = 0.02). Myocardial and peripheral norepinephrine and epinephrine extractions were similar for both groups. Taken together, these findings may suggest that chagasic patients with congestive heart failure have biochemical evidence of cardiac autonomic dysfunction with preservation of the peripheral sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614491     DOI: 10.1159/000176874

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  7 in total

1.  Cardiac resynchronization therapy for patients with chronic systolic heart failure secondary to Chagas cardiomyopathy in the 21st century.

Authors:  Reinaldo B Bestetti
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jan-Mar

2.  Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients.

Authors:  Ana Luiza Lunardi Rocha; Federico Lombardi; Manoel Otávio da Costa Rocha; Márcio Vinícius Lins Barros; Vladimir da Costa Val Barros; Adelina Martha Reis; Antonio Luiz Pinho Ribeiro
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

3.  Autonomic dysfunction and beta blocker therapy in Chagas heart disease.

Authors:  Reinaldo B Bestetti; Augusto Cardinalli-Neto
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

4.  Cardiac autonomic control mechanisms in the pathogenesis of chagas' heart disease.

Authors:  Diego F Dávila; Jose H Donis; Gabriela Arata de Bellabarba; Vanesa Villarroel; Francisco Sanchez; Lisbeth Berrueta; Siham Salmen; Barbara Das Neves
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-02

Review 5.  Carlos Chagas Discoveries as a Drop Back to Scientific Construction of Chronic Chagas Heart Disease.

Authors:  Reinaldo B Bestetti; Carolina Baraldi A Restini; Lucélio B Couto
Journal:  Arq Bras Cardiol       Date:  2016-05-24       Impact factor: 2.000

6.  Cardiac Sympathetic Activity and the Neuro-Humoral Theory on Heart Failure with Reduced Ejection Fraction: Have We Learned Enough?

Authors:  Thiago Quinaglia A C Silva; Otávio R Coelho-Filho
Journal:  Arq Bras Cardiol       Date:  2018-08       Impact factor: 2.000

7.  Sympathetic Dysautonomia in Heart Failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients.

Authors:  Viviane Santuari Parisotto Marino; Sandra Monetti Dumont; Luciene das Graças Mota; Daniela de Souza Braga; Stephanie Saliba de Freitas; Maria da Consolação Vieira Moreira
Journal:  Arq Bras Cardiol       Date:  2018-08-06       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.